Oasmia Pharmaceutical Ab (OASM) Annual Income Statement

Annual · GAAP · USD millions
Access OASM quarterly income statements →
This page allows investors to track Oasmia Pharmaceutical Ab's income statement performance across multiple reporting periods.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/OASM/income-statements
https://api.csimarket.com/api/v1/companies/OASM/fundamentals
https://api.csimarket.com/api/v1/companies/OASM/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Annual Report, GAAP in USD millions
ITEM
(Apr 30 2018)
2018
Revenues
Total Revenue0.38
Costs & Expenses
Gross Profit0.00
Depreciation & Amortization0.58
OtherOperating Income Expense0.21
Total operating costs including COS12.88
Operating income / -loss-12.50
Net Interest (-)Expense / Income0.00
Other loss / -income-132.30
Total costs & expenses121.18
Income & Taxes
Income / -loss before income taxes-30.15
Income after income taxes-30.15
Income / -loss from continuing operations-14.22
Non-controlling interests0.00
Net income / -loss-14.22
Income / -loss to shareholder-118.01
EBIT-30.15
EBITD-30.15
EBITDA-30.15
Earnings Per Share
Basic EPS (excl. extra items)0.00
Basic Net EPS0.00
Basic shares outstanding (Mill. of Units)166.20
Diluted Net EPS0.00
Diluted average shares (Mill. of Units)166.20
4 historic quarters locked

Sign in to unlock the full Oasmia Pharmaceutical Ab income statement history.

About OASM Annual Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-K filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-K filings
  • Filed with the SEC: n/a

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI